Background The efficacy and safety profiles of vaccines against SARS-CoV-2 in patients with
cancer is unknown. We aimed to assess the safety and immunogenicity of the BNT162b2 (…

Polycomb-repressive complex 2 (PRC2)-mediated histone methylation plays an important
role in aberrant cancer gene silencing and is a potential target for cancer therapy. Here we …

Genetic and epigenetic defects in Wnt/β-catenin signaling play important roles in colorectal
cancer progression. Here we identify DACT3, a member of the DACT (Dpr/Frodo) gene family…

Colorectal cancer patients often relapse after chemotherapy, owing to the survival of stem or
progenitor cells referred to as cancer stem cells (CSCs). Although tumor stromal factors are …

Metastatic tumour recurrence due to failed treatments remains a major challenge of breast
cancer clinical management. Here we report that interleukin-1 receptor-associated kinase 1 (…

Although 3-phosphoinositide–dependent protein kinase-1 (PDK1) has been predominately
linked to the phosphoinositide 3-kinase (PI3K)–AKT pathway, it may also evoke additional …

BRD4, a Bromodomain and Extraterminal (BET) protein family member, is a promising anti-cancer
drug target. However, resistance to BET inhibitors targeting BRD4 is common in solid …

Tumor recurrence remains the main reason for breast cancer–associated mortality, and
there are unmet clinical demands for the discovery of new biomarkers and development of …

The PP2A serine/threonine protein phosphatase serves as a critical cellular regulator of cell
growth, proliferation, and survival. However, how this pathway is altered in human cancer to …

Although small-molecule targeting of EZH2 appears to be effective in lymphomas carrying
EZH2 activating mutations, finding similar approaches to target EZH2-overexpressing …